Carbamate inhibitors (e.g., pyridostimine bromide) are used as a pre-exposure treatment for the prevention of organophosphorus poisoning. They work by blocking acetylcholinesterase's (AChE) native function and thus protect AChE against irreversible inhibition by organophosphorus compounds. However, carbamate inhibitors are known for many undesirable side-effects related to the carbamylation of AChE. In this Letter, 19 analogues of SAD-128 were prepared and evaluated as cholinesterase inhibitors. The screening results showed promising inhibitory ability of four compounds better to used standards (pralidoxime, obidoxime, BW284c51, ethopropazine, SAD-128). Four most promising compounds were selected for further molecular docking studies. The SAR was stated from obtained data. The former receptor studies were reported and discussed. The further in vivo studies were recommended in the view of OP pre-exposure treatment.

University of Defence Faculty of Military Health Sciences Department of Toxicology Trebesska 1575 500 01 Hradec Kralove Czech Republic

Citace poskytuje Crossref.org

Novel Group of AChE Reactivators-Synthesis, In Vitro Reactivation and Molecular Docking Study

Development of small bisquaternary cholinesterase inhibitors as drugs for pre-treatment of nerve agent poisonings